Search | eNauka

Research outputs

Sequential rescue treatments in steroid refractory ulcerative colitis: two-year follow-up [2017]

Protic, Marijana B; Seibold, F; Manser, C; Frei, Pascal; Mottet, Christian; Juillerat, Pascal; Knezevic, Tamara; Rogler, G; Beglinger, Christoph; Schoepfer, A;

Vavricka, Stephan;

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II [2021]

Reinisch, Walter; ...; Tarabar, Dino K; ...; (broj, koautora 18)

TURANDOT: a randomized, multicenter double-blind, placebo-controlled study of the safety and efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in patients with moderate to severe Ulcerative Colitis (UC) [2015]

Vermeire, Severine; ...; Tarabar, Dino K; ...; (broj, koautora 18)

Impact of depression on health related quality of life in Ulcerative Colitis patients-are we doing enough? A single tertiary center experience [2025]

Jakšić, D.; Vuksanović, S.; Topličanin, A.; Spirić-Milovančević, J.; Marić, Gorica ; Sokić-Milutinović, Aleksandra

Managing tuberculosis infection risk in inflammatory bowel disease patients before biological therapy initiation - Single-center experience [2025]

Topličanin, Aleksandar; Vuksanović, Saša; Spirić-Milovančević, Jelena; Nikolić, Andreja; Zgradić, Sanja ; Tončev, Ljubiša; Dragašević, Sanja ; Jovičić, Ivana; Đuranović, Srđan ; Pavlović-Marković, Aleksandra ;

Popović, Dragan ; Perović, Vladimir ; Popadić, Dušan ; Sokić-Milutinović, Aleksandra ;

Impact of age of subjects on the efficacy and safety of once-daily oral obefazimod in moderately to severely active ulcerative colitis: week 8 results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials [2026]

Magro, F; Tilg, H; Cataldi, F; Jacobstein, D; Rabbat, C; Shan, K; Nancey, S; Markovic, S; Rocco, R; Harlacher, L;

Yarur, A;

European evidence based consensus on surgery for ulcerative colitis [2014]

Øresland, Tom; Bemelman, Willem A.; Sampietro, Gianluca M.; Spinelli, Antonino; Windsor, Alastair; Ferrante, Marc; Marteau, Philippe; Zmora, Oded; Kotze, Paulo Gustavo; Espin-Basany, Eloy;

Tiret, Emmanuel; Sica, Giuseppe; Panis, Yves; Faerden, Arne E.; Biancone, Livia; Angriman, Imerio; Serclova, Zuzana; de, Buck van Overstraeten Anthony; Gionchetti, Paolo; Stassen, Laurents; Warusavitarne, Janindra; Adamina, Michel; Dignass, Axel; Eliakim, Rami; Magro, Fernando; D’Hoore, André;

Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension [2018]

Reinisch, Walter; Gibson, Peter R; Sandborn, William J; Feagan, Brian G; Strauss, Richard S; Johanns, Jewel; Padgett, Lakshmi; Adedokun, Omoniyi J; Colombel, Jean-Frederic; Collins, Judith;

Rutgeerts, Paul; Tarabar, Dino K; Marano, Colleen W;

Intraperitoneal injection of bone marrow derived-mesenchymal stem cells increases total number of colon-infiltrating inflammatory dendritic cells and macrophages and aggravates colitis in BALBc mice [2018]

Acovic, Aleksandar B ; Simovic-Markovic, Bojana J ; Gazdic, Marina ; Arsenijevic, Aleksandar N; Volarevic, Ana ; Kanjevac, Tatjana V ; Jovicic, Nebojsa M; Jakovljevic, Jelena; Arsenijevic, Milos; Arsenijevic, Nebojsa N ;

Lukic, Miodrag L; Volarevic, Vladislav B ;

Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for ulcerative colitis: A Phase 3, randomized, placebo-controlled study: Results of the LIBERTY-UC study [2023]

Sands, BE; ...; Sreckovic, S; ...; (broj, koautora 24)